QuidelOrtho Corp QDEL
2 targets with a reported result
Releases of the last 3 yearsThe numbers QDEL said it expected, in its earnings releases, next to what it then reported for the same period. 1 full-year target was dropped quietly: the next release, before the year ended, gave other targets for that year but said nothing about this one.
Target by target
Each target, with the sentence it came from · release and 10-Q or 10-K
| Target | What the company said | Reported | Result | |
|---|---|---|---|---|
| EBITDA (company-defined) Fiscal 2026 |
Given $615.00M to $630.00M release May 5, 2026
Lowered $540.00M to $560.00M release Aug 6, 2026
Kept $540.00M to $560.00M release Nov 3, 2026
|
– | No standard number | |
The company's wordsFull-year 2026 Updated (as of 5/5/26) Previous (as of Financial Guidance 2/11/26) … Adjusted EBITDA $615 - $630 million release May 5, 2026 Full-year 2026 Financial Updated Previous Guidance (as of 8/6/2026) (as of 5/5/2026) … Adjusted EBITDA $540 - $560 million release Aug 6, 2026 Full-year 2026 Financial As of 11/3/2026 As of 8/6/2026 Guidance … Adjusted EBITDA $540 - $560 million release Nov 3, 2026 | ||||
| Free cash flow (company-defined) Fiscal 2026 |
Given $100.00M to $120.00M release May 5, 2026
Kept $100.00M to $120.00M release Aug 6, 2026
|
– | No standard number | |
The company's wordsFull-year 2026 Updated (as of 5/5/26) Previous (as of Financial Guidance 2/11/26) … Free cash flow $100 - $120 million release May 5, 2026 Full-year 2026 Financial Updated Previous Guidance (as of 8/6/2026) (as of 5/5/2026) … Free cash flow Withdrawn $100 - $120 million release Aug 6, 2026 | ||||
| Diluted EPS (company-defined) Fiscal 2026 |
Given $1.80 to $2.00 release May 5, 2026
|
– | No standard number | |
The company's wordsFull-year 2026 Updated (as of 5/5/26) Previous (as of Financial Guidance 2/11/26) … Adjusted diluted earnings per share $1.80 - $2.00 release May 5, 2026 | ||||
| Revenue Fiscal 2026 |
Given $2.70B to $2.75B release May 5, 2026
Lowered $2.52B to $2.60B release Aug 6, 2026
Kept $2.52B to $2.60B release Nov 3, 2026
|
– | Not reported yet | |
The company's wordsFull-year 2026 Updated (as of 5/5/26) Previous (as of Financial Guidance 2/11/26) … Total revenues (reported) $2.70 - $2.75 billion release May 5, 2026 Full-year 2026 Financial Updated Previous Guidance (as of 8/6/2026) (as of 5/5/2026) … Total revenues (reported) $2.52 - $2.60 billion release Aug 6, 2026 Full-year 2026 Financial As of 11/3/2026 As of 8/6/2026 Guidance … Total revenues (reported) $2.52 - $2.60 billion release Nov 3, 2026 | ||||
| EBITDA (company-defined) Fiscal 2025 (ended Dec 28, 2025) |
Given $575.00M to $615.00M release Feb 12, 2025
Kept $575.00M to $615.00M release May 7, 2025
Kept $575.00M to $615.00M release Aug 5, 2025
Narrowed $585.00M to $605.00M release Nov 5, 2025
|
– | No standard number | |
The company's wordsBased on its current business outlook, the Company is issuing its fiscal year 2025 financial guidance, as follows: … Adjusted EBITDA $575 – $615 million release Feb 12, 2025 Based on its current business outlook, the Company is maintaining its fiscal 2025 financial guidance provided on February 12, 2025, as follows: … Adjusted EBITDA $575 – $615 million release May 7, 2025 Based on its current business outlook, the Company is reiterating its fiscal 2025 financial guidance provided on February 12, 2025, as follows: … Adjusted EBITDA $575 – $615 million release Aug 5, 2025 Based on its current business outlook, the Company is providing its fiscal 2025 financial guidance, as follows: … Adjusted EBITDA $585 - $605 million release Nov 5, 2025 | ||||
| Diluted EPS (company-defined) Fiscal 2025 (ended Dec 28, 2025) |
Given $2.07 to $2.57 release Feb 12, 2025
Kept $2.07 to $2.57 release May 7, 2025
Kept $2.07 to $2.57 release Aug 5, 2025
Lowered $2.00 to $2.15 release Nov 5, 2025
|
– | No standard number | |
The company's wordsBased on its current business outlook, the Company is issuing its fiscal year 2025 financial guidance, as follows: … Adjusted diluted EPS $2.07 - $2.57 release Feb 12, 2025 Based on its current business outlook, the Company is maintaining its fiscal 2025 financial guidance provided on February 12, 2025, as follows: … Adjusted diluted EPS $2.07 - $2.57 release May 7, 2025 Based on its current business outlook, the Company is reiterating its fiscal 2025 financial guidance provided on February 12, 2025, as follows: … Adjusted diluted EPS $2.07 - $2.57 release Aug 5, 2025 Based on its current business outlook, the Company is providing its fiscal 2025 financial guidance, as follows: … Adjusted diluted EPS $2.00 - $2.15 release Nov 5, 2025 | ||||
| Revenue Fiscal 2025 (ended Dec 28, 2025) |
Given $2.60B to $2.81B release Feb 12, 2025
Kept $2.60B to $2.81B release May 7, 2025
Kept $2.60B to $2.81B release Aug 5, 2025
Raised $2.68B to $2.74B release Nov 5, 2025
|
$2.73B 10-K filed 2026-02-19 |
Within the range | |
The company's wordsBased on its current business outlook, the Company is issuing its fiscal year 2025 financial guidance, as follows: … Total revenues (reported) $2.60 - $2.81 billion release Feb 12, 2025 Based on its current business outlook, the Company is maintaining its fiscal 2025 financial guidance provided on February 12, 2025, as follows: … Total revenues (reported) $2.60 - $2.81 billion release May 7, 2025 Based on its current business outlook, the Company is reiterating its fiscal 2025 financial guidance provided on February 12, 2025, as follows: … Total revenues (reported) $2.60 - $2.81 billion release Aug 5, 2025 Based on its current business outlook, the Company is providing its fiscal 2025 financial guidance, as follows: … Total revenues (reported) $2.68 - $2.74 billion release Nov 5, 2025 | ||||
| EBITDA (company-defined) Fiscal 2024 (ended Dec 29, 2024) |
Given $530.00M to $550.00M release Nov 7, 2024
|
– | No standard number | |
The company's wordsThe Company reinstated its full year 2024 financial guidance as of November 7, 2024, as follows: … Adjusted EBITDA $530 – $550 million release Nov 7, 2024 | ||||
| Diluted EPS (company-defined) Fiscal 2024 (ended Dec 29, 2024) |
Given $1.69 to $1.91 release Nov 7, 2024
|
– | No standard number | |
The company's wordsThe Company reinstated its full year 2024 financial guidance as of November 7, 2024, as follows: … Adjusted diluted EPS $1.69 - $1.91 release Nov 7, 2024 | ||||
| Revenue Fiscal 2024 (ended Dec 29, 2024) |
Given $2.76B to $3.07B release Feb 13, 2024
Lowered $2.75B to $2.80B release Nov 7, 2024
|
$2.78B 10-K filed 2025-02-27 |
Within the range | |
The company's wordsBased on its current business outlook, the Company is providing fiscal year 2024 financial guidance, as follows: … Total revenues (reported) $2.76 - $3.07 billion release Feb 13, 2024 The Company reinstated its full year 2024 financial guidance as of November 7, 2024, as follows: … Total revenues (reported) $2.75 - $2.80 billion release Nov 7, 2024 | ||||
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (14 releases since 2024-02-13), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.
Sources
The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.
Also
Earnings releases: each release in full.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/QDEL/export.csv") into a cell.